CliffBio
small molecule

PREDNISOLONE SODIUM PHOSPHATE

PREDNISOLONE SODIUM PHOSPHATE

Loss of exclusivity—loss of exclusivity
CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand namePREDNISOLONE SODIUM PHOSPHATE
Active ingredientPREDNISOLONE SODIUM PHOSPHATE
StrengthEQ 0.9% PHOSPHATE
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalOctober 1991
Marketing statusDISCN

More from Alcon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

PREDNISOLONE SODIUM PHOSPHATE patent cliff — loss of exclusivity — | CliffBio